Page last updated: 2024-10-17

3-hydroxybutyric acid and Epithelial Ovarian Cancer

3-hydroxybutyric acid has been researched along with Epithelial Ovarian Cancer in 1 studies

3-Hydroxybutyric Acid: BUTYRIC ACID substituted in the beta or 3 position. It is one of the ketone bodies produced in the liver.
3-hydroxybutyric acid : A straight-chain 3-hydroxy monocarboxylic acid comprising a butyric acid core with a single hydroxy substituent in the 3- position; a ketone body whose levels are raised during ketosis, used as an energy source by the brain during fasting in humans. Also used to synthesise biodegradable plastics.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Scalise, CB1
Norian, L1
Demark-Wahnefried, W1

Other Studies

1 other study available for 3-hydroxybutyric acid and Epithelial Ovarian Cancer

ArticleYear
Long-Term Glucose Restriction with or without Beta-Hydroxybutyrate Enrichment Distinctively Alters Epithelial-Mesenchymal Transition-Related Signaling in Ovarian Cancer Cells.
    Nutrition and cancer, 2022, Volume: 74, Issue:3

    Topics: 3-Hydroxybutyric Acid; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Epithelial-Me

2022